Irritable Bowel Syndrome Trial, Recruiting (NCT05721742)

Irritable Bowel Syndrome Trial, Recruiting NCT05721742 Sponsor: Nova Scotia Health Authority Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT05721742 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had recurring stomach pain at least one day per week on average over the last 3 months, and this pain is connected to at least two of the following: going to the toilet, changes in how often you have bowel movements, or changes in what your stools look like
You are willing to make changes to your diet as part of the study
You have access to a phone, tablet, or computer that can be used to take part in online dietary education sessions

Who may not be able to join:

You are aged 50 or older and your symptoms started for the first time within the past year
You have noticed bleeding from your back passage (rectum)
You have been diagnosed with Inflammatory Bowel Disease (such as Crohn's disease or ulcerative colitis)
You have lost weight recently without an obvious reason
You have had surgery on your digestive system that involved removing your gallbladder or part of your bowel
You have or have had an eating disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05721742

Sponsor: Nova Scotia Health Authority

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

More information: https://clinicaltrials.gov/study/NCT05721742

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had recurring stomach pain at least one day per week on average over the last 3 months, and this pain is connected to at least two of the following: going to the toilet, changes in how often you have bowel movements, or changes in what your stools look like
You are willing to make changes to your diet as part of the study
You have access to a phone, tablet, or computer that can be used to take part in online dietary education sessions

Who may not be able to join:

You are aged 50 or older and your symptoms started for the first time within the past year
You have noticed bleeding from your back passage (rectum)
You have been diagnosed with Inflammatory Bowel Disease (such as Crohn's disease or ulcerative colitis)
You have lost weight recently without an obvious reason
You have had surgery on your digestive system that involved removing your gallbladder or part of your bowel
You have or have had an eating disorder

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nova Scotia Health Authority

Registry

ClinicalTrials.gov

Start date

16 May 2023

Est. completion

1 May 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

IBS Symptom Severity; IBS Symptom Severity; IBS Specific Quality of Life; IBS Specific Quality of Life; Patient Quality of Life; Patient Quality of Life; Total number Inpatient services in the last 3 months; Total number Inpatient services in the last 3 months; Total number Outpatient appointments in the last 3 months; Total number Outpatient appointments in the last 3 months; Volume of referrals to Dietician; Volume of referrals to Online Group Session; Patient satisfaction with the Virtual Dietician led 1 on 1 education session; Volume of 1 on 1 dietary consults completed; Number of online m...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov